Jacoby Dana Lynn 4

What Happened Dana Lynn Jacoby, a director of biote Corp. (BTMD), was granted two equity awards on May 12, 2026: 37,777 Deferred Settlement RSUs and 130,000 shares issued as derivative awards. Both grants show an acquisition price of $0.00 (i.e., awarded, not purchased), so no cash changed hands at grant.

Key Details

• Transaction date: May 12, 2026; Form 4 filed May 13, 2026 (filed timely).
• Award amounts and prices: 37,777 RSUs @ $0.00; 130,000 derivative award shares @ $0.00.
• Shares owned after transaction: not specified in the reported Form 4.
• Footnotes of note:
  • F1: Each Deferred Settlement RSU equals the economic value of one share of Class A common stock.
  • F2: The Deferred Settlement RSUs are fully vested on grant, but settlement is deferred until the earlier of calendar year 2027 or the reporting person’s separation from service.
  • F3: The 130,000 award vests on the earlier of May 12, 2027 or the day before the issuer’s 2027 Annual Meeting, subject to continuous service.
• No sale, purchase for cash, or option exercise was reported—these are grant/award transactions.

Context

• Deferred Settlement RSUs mean Jacoby has the economic right to receive shares later (settlement deferred to 2027 or separation), so she does not yet hold all underlying shares outright.
• The 130,000 award is subject to future vesting based on continued service (not immediately transferable if unvested).
• These are grants (A = award) rather than open-market buys or sales; awards are common compensation for directors and do not by themselves indicate a buy/sell signal about the stock.